List date(s) this work was published or aired.
May-11
Provide a brief synopsis of the story or stories, including any significant findings.
A longitudinal study of magnetic resonance imaging (MRI) scans carried out among antipsychotic-treated patients with schizophrenia provides additional evidence supporting the view that antipsychotics are associated with reductions in grey matter (GM) and white matter (WM), and that greater brain volume reductions are associated with longer antipsychotic treatment.
- MRI study finds all classes of antipsychotics associated with decreased brain tissue volumes in schizophrenia patients.
- Increasing use of antipsychotics across various age groups, and for indications other than schizophrenia, warrants closer investigation of the risks and benefits of long-term use of these medications.
- Authors caution that the findings do not imply that schizophrenia patients should stop taking their antipsychotic medications.
Explain types of documents, data or Internet resources used. Were FOI or public records act requests required? How did this affect the work?
Peer-reviewed published research.
Explain types of human sources used.
Interview with lead author.
Results:
NA
Follow-up (if any). Have you run a correction or clarification on the report or has anyone come forward to challenge its accuracy? If so, please explain.
NA
Advice to other journalists planning a similar story or project.
NA